MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
Public ClinicalTrials.gov record NCT03545607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 3 study to examine the safety and effectiveness of the allogeneic, adult stem cell investigational product, MultiStem, in adults who have suffered an acute ischemic stroke in the previous 18-36 hours.
Study identification
- NCT ID
- NCT03545607
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 206 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2018
- Primary completion
- Sep 30, 2024
- Completion
- Sep 30, 2024
- Last update posted
- Aug 10, 2026
2018 – 2024
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Athersys Investigational Site 128 | Phoenix | Arizona | 85013 | — |
| Athersys Investigational Site 122 | Palo Alto | California | 94304 | — |
| Athersys Investigational Site 127 | Sacramento | California | 95817 | — |
| Athersys Investigational Site 129 | Clearwater | Florida | 33756 | — |
| Athersys Investigational Site 108 | Miami | Florida | 33136 | — |
| Athersys Investigational Site 103 | Augusta | Georgia | 30912 | — |
| Athersys Investigational Site 121 | Chicago | Illinois | 60201 | — |
| Athersys Investigational Site 119 | Kansas City | Kansas | 66160 | — |
| Athersys Investigational Site 124 | Wichita | Kansas | 67214 | — |
| Athersys Investigational Site 113 | Boston | Massachusetts | 02114 | — |
| Athersys Investigational Site 125 | Minneapolis | Minnesota | 55455 | — |
| Athersys Investigational Site 111 | Jackson | Mississippi | 39216 | — |
| Athersys Investigational Site 109 | Akron | Ohio | 44304 | — |
| Athersys Investigational Site 104 | Cleveland | Ohio | 44195 | — |
| Athersys Investigational Site 130 | Toledo | Ohio | 43606 | — |
| Athersys Investigational Site 102 | Portland | Oregon | 97239 | — |
| Athersys Investigational Site 107 | Hershey | Pennsylvania | 17033 | — |
| Athersys Investigational Site 106 | Pittsburgh | Pennsylvania | 15213 | — |
| Athersys Investigational Site 118 | Columbia | South Carolina | 29203 | — |
| Athersys Investigational Site 115 | Chattanooga | Tennessee | 37403 | — |
| Athersys Investigational Site 101 | Houston | Texas | 77030 | — |
| Athersys Investigational Site 105 | Houston | Texas | 77030 | — |
| Athersys Investigational Site 110 | Salt Lake City | Utah | 84112 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03545607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03545607 live on ClinicalTrials.gov.